Pneumococcal Polysaccharide Conjugated Vaccine
Indications
Pneumococcal Polysaccharide Conjugated Vaccine is used for:
Active immunization for the prevention of pneumococcal disease, Meningitis, Sepsis, Bacteraemic pneumonia, Pleural empyema, Bacteraemia, Pneumococcal pneumonia
Adult Dose
Not for adult
Child Dose
Intramuscular
Active immunisation against pneumococcal disease
Infant 6 wk-6 mth:
3-dose Primary series
1st dose given at 2 mth or at 6 wk of age, with 1-mth interval between doses.
A booster dose is recommended at least 6 months after the last priming dose.
2-dose Primary series
2 doses w/ the 1st dose given at 2 mth of age, w/ 2-mth interval between 1st & 2nd dose.
Infants 7-11 mth:
2 doses at least 1 mth apart, with the 3rd dose given in the 2nd yr of life.
Infant & childn 12 mth-5 yr previously unvaccinated
2 doses w/ at least 2 mth interval between doses.
Pre-term infant born at least 27 wk of gestation
3 doses w/ the 1st dose given at 2 mth of age, w/ 1-mth interval between doses.
Booster dose Administer at least 6 mth after the last primary dose.
Renal Dose
Administration
Contra Indications
Hypersensitivity to any component of the vaccine. Febrile illness, acute disease, anaphylactic reaction to a previous dose, severe primary immunodeficiency.
Precautions
Severe renal, hepatic, cardiac, vascular &/or pulmonary dysfunction. Patients on immunosuppressants may be unable to attain required antibody titres. Pregnancy & lactation. Efficacy may be reduced in multiple myeloma, Hodgkin's and non-Hogkin's lymphoma, especially during treatment and in chronic alcoholism. Vaccine should be given 2 wk before starting immunosuppressive treatment or at least 3 mth after treatment completion.
Pregnancy-Lactation
Pregnancy Category: C
Lactation: N/A
Interactions
Adequate response may not be elicited w/ immunosuppressants.
Adverse Effects
Side effects of Pneumococcal Polysaccharide Conjugated Vaccine :
Local inj site reactions, warmth, erythema & swelling; fever, headache, malaise.
Mechanism of Action
These products convey active immunity via stimulation of production of endogenously produced antibodies .